Ads
-
Related paper
- Design of new potent HTLV-1 protease inhibitors: in silico study
- In-silico Design of Oxadiazole Hybrids as Potential Inhibitors of Dengue Virus NS2B-NS3 Protease
- Identification of potential SARS-CoV-2 main protease inhibitors from Ficus Carica Latex: An in-silico approach
- In Silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease: Targets for COVID-19
- In silico Pharmacological Screening of Nitrogen containing Bisphosphonate Conjugate with Hydroxyapatite Active Constituents in Finding Potent Inhibitors for Bone Related Diseases
- In Silico Identification of Some Novel Ketoamides as Potential Pan-Genotypic HCV NS3/4A Protease Inhibitors with Drug-Likeness, Pharmacokinetic ADME Profiles and Synthetic Accessibility Predictions
- Chemoinformatic Design of Phthalazinone Analogues as Novel Dengue Virus NS2B-NS3 Protease Inhibitors with Enhanced Pharmacokinetics
- Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology
- PROTEASE INHIBITORS: A REVIEW
- DESIGNING, DOCKING AND TOXICITY STUDIES OF NOVEL HIV-1 PROTEASE INHIBITORS